gist

(redirected from gists)
Also found in: Dictionary, Medical, Legal, Encyclopedia.
Related to gists: GitHub
Graphic Thesaurus  🔍
Display ON
Animation ON
Legend
Synonym
Antonym
Related
  • noun

Synonyms for gist

Synonyms for gist

Synonyms for gist

the central meaning or theme of a speech or literary work

References in periodicals archive ?
Cytoreductive surgery alone for recurrent, metastatic, or unresectable GISTs is not recommended.
His upper gastrointestinal endoscopy revealed an oval shaped mass over anterior wall of stomach at cardia, along lesser curvature suggestive of GIST.
The histopathologic findings matched GIST with a high probability of relapse according to the localization, size, mitotic activity and Ki-67 values.
In addition to CD117 and DOG-1, GISTs are typically positive for CD34 and show variable positivity for smooth muscle actin (SMA) on immunohistochemistry (Figure 2, A through C).
GISTs with 1-5 mitosis/ 50 HPF are classified as a low grade, and GISTs with a mitosis of 10/10 HPF are classified as high-grade group.
Imatinib, the target therapy for GISTs and a selective tyrosine kinase inhibitor, primarily acts on tyrosine kinase: Abl, c-kit, and platelet-derived growth factor receptor.
Imatinib mesylate is indicated in patients with advanced GISTs.
In differential diagnosis, tumors that must be separated from LMSs and colonic GISTs include the uterine-type LMs attached to the colon but arising externally to it (uniformly positive for actin and desmin), inflammatory myofibroblastic tumors (nega tive for CD117) and inflammatory fibrosarcoma, liposarcoma adherent to the colon (negative for CD117), and schwannoma (diffusely positive for S-100 protein and negative for CD117 and CD34) [4].
GISTs are generally asymptomatic; however, they can also present as abdominal pain, bleeding, or mechanical obstruction.
During 5 years (2007-2012), we retrieved 50 cases of GISTs from the archives of the affiliated hospitals of Shiraz University of Medical Sciences.
2) Perhaps, the most critical development that distinguished GIST as a unique clinical entity was the discovery of c-kit proto-oncogene gain-of-function mutations in these tumors by Hirota and collegues in 1998.
GISTs can arise from all parts of the gastrointestinal tract--stomach (50-60%), small intestine (30-40%), colon/rectum (5-10%) and esophagus (5%) (Stamatakos, Douzinas, Stefanaki, Safioleas et al.
1 GISTs can be seen as either spindled, epithelioid cells or as a combination of both of these cell types.
The discovery of oncogenic KIT kinase mutations in GISTs and the introduction of kinase inhibitor therapies have led to a rapid evolution in the understanding of these tumors.